http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019071449-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f1a30682c7f24ace5f2b16c6be633b6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05K999-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-20
filingDate 2018-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc4aa2be5ac3e1fa5be329ef82d37a05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_124a07b4a5698080cfe427c3c707afb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16d7bec1c59cca6f3d25cc122e1a5ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54b901e7af441ed7655c9d03e4ce85f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38b6e621e75db10b32344f75e850761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a29a936fdc09921bd78363f178d7ad6
publicationDate 2019-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019071449-A1
titleOfInvention Solid state forms of spiro-oxindole compounds
abstract The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021050470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018201594-A1
priorityDate 2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160686055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452436591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227804981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20481629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49836093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236269977

Total number of triples: 39.